United States - English - NLM (National Library of Medicine)

direct rx - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin tablet, usp is contraindicated in patients with known hyper-sensitivity to oxaprozin. oxaprozin tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma). oxaprozin tablet, usp is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings). oxaprozin tablet, usp is contraindicated in patients with active gastrointestinal bleeding (see warnings oxaprozin is a non-narcotic drug. usually reliable animal studies have indicated that oxaprozin has no known addiction potential in humans. oxaprozin is indicated: • for relief of the signs and symptoms of osteoarthritis • for relief of t

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - carefully consider the potential benefits and risks of  oxaprozin tablets usp and other treatment options before deciding to use  oxaprozin tablets usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). oxaprozin  tablets usp are indicated: oxaprozin  is contraindicated in patients with known hypersensitivity to oxaprozin. oxaprozin  should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, pre-existing asthma ). oxaprozin is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). oxaprozin is a non-narcotic drug. usually reliable animal studies have indicated that oxaprozin has no known addiction potential in humans. no patient

United States - English - NLM (National Library of Medicine)

eon labs, inc. - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin tablets are indicated: oxaprozin is contraindicated in the following patients: risk summary use of nsaids, including oxaprozin, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and duration of oxaprozin use between about 20 and 30 weeks of gestation, and avoid oxaprozin use at about 30 weeks of gestation and later in pregnancy (see clinical considerations, data). premature closure of fetal ductus arteriosus use of nsaids, including oxaprozin, at about 30 weeks gestation or later in pregnancy increases the risk of premature closure of the fetal ductus arteriosus. oligohydramnios/neonatal renal impairment use of nsaids at about 20 weeks gestation or later in pregnancy has been associated with cases of fetal renal dysfunction leading to oligohydramnios, and in some cases, neonatal renal impairment. data from observational studies regarding other potential em

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - carefully consider the potential benefits and risks of oxaprozin tablet, usp and other treatment options before deciding to use oxaprozin tablet, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). oxaprozin tablet, usp is indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin tablet, usp is contraindicated in patients with known hyper-sensitivity to oxaprozin. oxaprozin tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma). oxaprozin tablet, usp is contraindicated for the treatment of peri-operative pain in the setti

United States - English - NLM (National Library of Medicine)

california pharmaceuticals llc - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin tablets is a non-steroidal anti-inflammatory drug indicated for: - relief of signs and symptoms of osteoarthritis (oa) (1) - relief of signs and symptoms of rheumatoid arthritis (ra) (1) - relief of signs and symptoms of juvenile rheumatoid arthritis (jra) (1) - known hypersensitivity to oxaprozin or any components of the drug product (4) - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids (4) - in the setting of cabg surgery (4) oxaprozin is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to oxaprozin or any components of the drug product [see warnings and precautions (5.7, 5.9)] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. - severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)] - in the setting of coron

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to oxaprozin or any components of the drug product [see warnings and precautions (5.7, 5.9)]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see  warnings and precautions (5.7, 5.8) ]. - in the setting of cabg surgery [see warnings and precautions (5.1 ) ]. risk summary use of nsaids, including oxaprozin, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and

United States - English - NLM (National Library of Medicine)

greenstone llc - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin is indicated: oxaprozin is contraindicated in the following patients: risk summary use of nsaids, including oxaprozin, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and duration of oxaprozin use between about 20 and 30 weeks of gestation, and avoid oxaprozin use at about 30 weeks of gestation and later in pregnancy (see clinical considerations, data) . premature closure of fetal ductus arteriosus use of nsaids, including oxaprozin, at about 30 weeks gestation or later in pregnancy increases the risk of premature closure of the fetal ductus arteriosus. oligohydramnios/neonatal renal impairment use of nsaids at about 20 weeks gestation or later in pregnancy has been associated with cases of fetal renal dysfunction leading to oligohydramnios, and in some cases, neonatal renal impairment. data from observational studies regarding other potential embryofeta

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - carefully consider the potential benefits and risks of oxaprozin tablet, usp and other treatment options before deciding to use oxaprozin tablet, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). oxaprozin tablet, usp is indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin tablet, usp is contraindicated in patients with known hyper-sensitivity to oxaprozin. oxaprozin tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma). oxaprozin tablet, usp is contraindicated for the treatment of peri-operative pain in

United States - English - NLM (National Library of Medicine)

stat rx usa llc - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - carefully consider the potential benefits and risks of oxaprozin tablets and other treatment options before deciding to use oxaprozin tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). oxaprozin tablets are indicated: - for relief of the signs and symptoms of osteoarthritis·    - for relief of the signs and symptoms of rheumatoid arthritis·    - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin tablets are contraindicated in patients with known hypersensitivity to oxaprozin. oxaprozin tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings,  anaphylactoid reactions and precautions, preexisting asthma ). oxaprozin tablets are contraindicated for the treatment of peri-operative pain in the settin

United States - English - NLM (National Library of Medicine)

a-s medication solutions - oxaprozin (unii: mhj80w9lrb) (oxaprozin - unii:mhj80w9lrb) - oxaprozin 600 mg - oxaprozin tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of juvenile rheumatoid arthritis oxaprozin is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to oxaprozin or any components of the drug product [see warnings and precautions (5.7, 5.9) ]   - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. - severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8 )]   - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)]   risk summary use of nsaids, including oxaprozin, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including oxaprozin, in pregnant w